Dozens of lots of the generic version of the cholesterol drug Lipitor have been recalled because they may contain tiny glass particles. Ranbaxy Pharmaceuticals, a subsidiary of Ranbaxy Laboratories Ltd. is operating under increased scrutiny from the United States Food and Drug Administration (FDA) because of possible multiple quality lapses at several of its factories over the past several years.
This company is a subsidiary of India’s biggest drug maker. Besides this recall, the FDA is also alleging that this company has lied about test results for more than 24 of its generic drugs during the past several years. There have also been a string of manufacturing deficiencies that has previously led United States regulators to bar imports of the Indian company’s medicines.
On November 23, 2012, Ranbaxy posted a notice on its United States’ website indicating it is recalling the 10 -, 20 – and 40 – milligram doses of the tablets atorvastin calcium. This is the generic brand of Lipitor, a drug used to fight cholesterol. Lipitor has been the world’s top-selling drug for many years. The website makes it clear that Ranbaxy is proactively recalling these particular drug product lots out of an abundance of caution.
Patients who may believe that their prescription is one of those recalled can contact their pharmacy to help determine whether their prescription was made by Ranbaxy or another generic drug manufacturer, and if it is from Ranbaxy, whether it came from a recalled lot.